塔尔苏斯制药 TARS
$68.60 +$1.08 (+1.60%)
休市 · Nov 8, 5:10 am ET · 最新盘后价 $70.00 +2.04%
开盘$67.78
昨收$67.52
当日区间$66.53 – $69.04
成交量1.09M
市值$3.38B
市盈率（TTM）–
股息率–
基本面
最新报告季度：Q2, ended Jun 2026
营收$173.91M+69.4% YoY
营业利润-$19.91M+10.3% YoY
净利润-$18.55M+8.8% YoY
摊薄每股收益-$0.43+10.4% YoY
自由现金流$57.15M+288.1% YoY
经营现金流$61.22M
营收，近8个季度
净利润，近8个季度
各季度摊薄每股收益
各季度自由现金流
年度营收
盈利能力与资产负债表
毛利率93.3%
营业利润率-8.0%
净利率-7.7%
净资产收益率-13.7%
资产收益率-8.4%
投入资本回报率-12.3%
流动比率3.20
负债/资产比率43.3%
现金及投资$449.69M
总负债$72.76M
净现金（净负债）$376.93M
自由现金流/营收9.2%
利润表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 报告营业总收入 | $173.91M | $162.05M | $451.36M | $151.67M | $118.70M |
| 营业总收入 | $173.91M | $162.05M | $451.36M | $151.67M | $118.70M |
| 营业成本 | $12.11M | $9.40M | $30.68M | $10.93M | $8.31M |
| 毛利润 | $161.80M | $152.66M | $420.68M | $140.74M | $110.39M |
| 营业费用 | $181.71M | $158.78M | $491.65M | $148.72M | $124.92M |
| 销售及管理费用 | $150.70M | $136.43M | $427.32M | $130.68M | $108.63M |
| 研发费用 | $31.01M | $22.35M | $64.32M | $18.04M | $16.28M |
| 营业利润 | -$19.91M | -$6.12M | -$70.97M | -$7.98M | -$14.53M |
| 非经营性利息净收入（支出） | $1.54M | $1.59M | $6.81M | $1.74M | $1.85M |
| 非经营性利息收入 | $3.70M | $3.72M | $15.75M | $3.95M | $4.11M |
| 非经营性利息支出 | $1.99M | $1.97M | $8.34M | $2.06M | $2.12M |
| 其他财务成本合计 | $165,000.00 | $159,000.00 | $593,000.00 | $156,000.00 | $152,000.00 |
| 其他收入（支出） | $2.53M | -$87,000.00 | -$202,000.00 | -$74,000.00 | $98,000.00 |
| 证券出售收益 | $2.81M | – | – | – | – |
| 其他非经营性收入（支出） | -$281,000.00 | -$87,000.00 | -$202,000.00 | -$74,000.00 | $98,000.00 |
| 税前利润 | -$15.84M | -$4.62M | -$64.36M | -$6.31M | -$12.59M |
| 税费 | $2.72M | $2.35M | $2.06M | – | – |
| 净利润 | -$18.55M | -$6.97M | -$66.42M | -$8.37M | -$12.59M |
| 持续经营利润 | -$18.55M | -$6.97M | -$66.42M | -$8.37M | -$12.59M |
| 归属母公司净利润 | -$18.55M | -$6.97M | -$66.42M | -$8.37M | -$12.59M |
| 归属普通股股东净利润 | -$18.55M | -$6.97M | -$66.42M | -$8.37M | -$12.59M |
| 基本每股收益 | -$0.43 | -$0.16 | -$1.59 | -$0.20 | -$0.30 |
| 摊薄每股收益 | -$0.43 | -$0.16 | -$1.59 | -$0.20 | -$0.30 |
| 特殊收益（费用） | – | – | $0.00 | $0.00 | $0.00 |
资产负债表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 总资产 | $611.14M | $581.14M | $562.16M | $562.16M | $534.56M |
| 流动资产合计 | $561.99M | $537.23M | $522.78M | $522.78M | $501.70M |
| 现金及现金等价物与短期投资 | $449.69M | $388.73M | $417.27M | $417.27M | $401.84M |
| -现金及现金等价物 | $204.60M | $102.19M | $183.64M | $183.64M | $112.72M |
| -短期投资 | $245.10M | $286.54M | $233.63M | $233.63M | $289.11M |
| 应收款 | $98.31M | $117.21M | $87.11M | $87.11M | $74.34M |
| -应收账款 | $96.03M | $100.34M | $85.06M | $85.06M | $72.62M |
| -其他应收款 | $2.28M | $16.86M | $2.05M | $2.05M | $1.72M |
| 预付资产 | $9.61M | $26.72M | $13.47M | $13.47M | $21.70M |
| 存货 | $4.38M | $4.57M | $4.37M | $4.37M | $3.84M |
| 受限现金 | $0.00 | $0.00 | $560,000.00 | $560,000.00 | – |
| 非流动资产合计 | $49.15M | $43.91M | $39.38M | $39.38M | $32.86M |
| 固定资产净值 | $30.40M | $27.67M | $21.75M | $21.75M | $15.98M |
| -固定资产原值 | $32.25M | $29.96M | $23.84M | $23.84M | $18.61M |
| -累计折旧 | -$1.85M | -$2.30M | -$2.10M | -$2.10M | -$2.63M |
| 投资及预付款 | $6.68M | $3.87M | $3.87M | $3.87M | $3.00M |
| 商誉及其他无形资产 | $6.89M | $7.13M | $7.37M | $7.37M | $7.61M |
| 其他非流动资产 | $5.19M | $5.24M | $6.40M | $6.40M | $6.27M |
| 负债合计 | $264.41M | $232.18M | $218.73M | $218.73M | $199.48M |
| 流动负债合计 | $175.75M | $143.51M | $135.70M | $135.70M | $117.05M |
| 应付款 | $51.64M | $31.96M | $27.30M | $27.30M | $47.07M |
| -应付账款 | $40.14M | $24.13M | $16.39M | $16.39M | $40.64M |
| -应付税款合计 | $2.11M | $563,000.00 | $1.81M | $1.81M | – |
| -其他应付款 | $9.39M | $7.27M | $9.10M | $9.10M | $6.43M |
| 一年内应计费用 | $98.69M | $79.05M | $86.22M | $86.22M | $69.90M |
| 其他流动负债 | $25.43M | $32.50M | $22.18M | $22.18M | – |
| 非流动负债合计 | $88.66M | $88.68M | $83.04M | $83.04M | $82.43M |
| 长期债务及融资租赁负债 | $72.76M | $72.60M | $72.44M | $72.44M | $72.28M |
| -长期债务 | $72.76M | $72.60M | $72.44M | $72.44M | $72.28M |
| 其他非流动负债 | $15.90M | $16.08M | $10.60M | $10.60M | $10.15M |
| 股东权益合计 | $346.73M | $348.95M | $343.43M | $343.43M | $335.08M |
| 股东权益 | $346.73M | $348.95M | $343.43M | $343.43M | $335.08M |
| 股本 | $6,000.00 | $6,000.00 | $6,000.00 | $6,000.00 | $6,000.00 |
| -普通股 | $6,000.00 | $6,000.00 | $6,000.00 | $6,000.00 | $6,000.00 |
| -优先股 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 资本公积 | $799.43M | $782.84M | $769.67M | $769.67M | $753.04M |
| 留存收益 | -$452.15M | -$433.60M | -$426.63M | -$426.63M | -$418.26M |
| 不影响留存收益的损益 | -$557,000.00 | -$298,000.00 | $381,000.00 | $381,000.00 | $289,000.00 |
| -一年内到期融资租赁负债 | – | – | $0.00 | $0.00 | $80,000.00 |
| 短期债务及融资租赁负债 | – | – | – | – | $80,000.00 |
现金流量表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 经营活动现金流 | $61.22M | -$24.65M | -$12.45M | $19.33M | $18.26M |
| 持续经营经营活动现金流净额 | $61.22M | -$24.65M | -$12.45M | $19.33M | $18.26M |
| 持续经营净利润 | -$18.55M | -$6.97M | -$66.42M | -$8.37M | -$12.59M |
| 折旧、折耗与摊销 | $1.00M | $437,000.00 | $1.82M | $443,000.00 | $460,000.00 |
| 其他非现金项目 | $258,000.00 | $236,000.00 | $1.28M | $310,000.00 | $357,000.00 |
| 营运资金变动 | $68.63M | -$29.48M | $14.64M | $13.58M | $19.33M |
| -应收款变动 | $18.92M | -$30.10M | -$39.05M | -$12.77M | -$14.10M |
| -存货变动 | $198,000.00 | -$196,000.00 | -$1.75M | -$536,000.00 | $37,000.00 |
| -预付资产变动 | $17.11M | -$13.24M | $1.72M | $8.19M | $7.98M |
| -应付账款及应计费用变动 | $19.05M | -$1.54M | $8.86M | -$26.31M | $39.12M |
| -其他流动资产变动 | $55,000.00 | $141,000.00 | -$527,000.00 | -$381,000.00 | -$373,000.00 |
| -其他流动负债变动 | $13.30M | $15.46M | $45.39M | $45.39M | -$13.33M |
| 投资活动现金流净额 | $37.88M | -$58.56M | -$42.12M | $49.27M | -$4.74M |
| 持续经营投资活动现金流净额 | $37.88M | -$58.56M | -$42.12M | $49.27M | -$4.74M |
| 固定资产购置及出售净额 | -$4.07M | -$5.82M | -$9.86M | -$6.36M | -$1.91M |
| 投资购置及出售净额 | $41.95M | -$52.74M | -$32.26M | $55.63M | -$2.83M |
| 筹资活动现金流 | $3.30M | $1.20M | $143.39M | $2.31M | $2.56M |
| 持续经营筹资活动现金流净额 | $3.30M | $1.20M | $143.39M | $2.31M | $2.56M |
| 普通股发行净额 | $0.00 | $0.00 | $134.77M | $0.00 | $0.00 |
| 股票期权行使所得 | $3.30M | $1.20M | $8.62M | $2.31M | $2.56M |
| 期末现金余额 | $206.60M | $104.19M | $186.20M | $186.20M | $115.29M |
| 现金净变动 | $102.40M | -$82.01M | $88.82M | $70.92M | $16.08M |
| 期初现金余额 | $104.19M | $186.20M | $97.38M | $115.29M | $99.21M |
| 自由现金流 | $57.15M | -$30.47M | -$22.31M | $12.97M | $16.35M |
| 无形资产购置及出售净额 | – | – | $0.00 | – | – |
| 债务发行及偿还净额 | – | – | $0.00 | $0.00 | – |
| 持续经营损益 | – | – | – | – | -$12,000.00 |
暂无评论——快来第一个聊聊 TARS。
登录后参与讨论。